Mallik Rettiganti
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Arkansas Children's Hospital (2011–2019); University of Arkansas Medical Center (2016); The Ohio State University (2012)
Formerly Arkansas Affiliated with UAMS through 2019; recent publications list Eli Lilly (United States).
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Mallik Rettiganti's research has focused on the investigation of pharmacological effects and toxicity, particularly concerning the metabolism of genetic disorders. Their work has explored methods for assessing these effects and understanding the underlying disease mechanisms. Rettiganti's publications indicate a recent focus on meta-analyses and systematic reviews within this area of study.
Metrics
- h-index: 5
- Publications: 8
- Citations: 76
Selected Publications
-
Prevalence, Patterns, and Predictors: A Statewide Longitudinal Study of Childhood Obesity (2019)
-
Long-term Walnut Oral Immunotherapy Induces Clinically Relevant Treatment Responses in Tree Nut Allergic Children (2017)
-
Tolerance of baked-milk in milk-triggered children with eosinophilic esophagitis (EoE) (2017)
-
Insulin Pump Therapy Started at the Time of Diagnosis: Effects on Glycemic Control and Pancreatic β-Cell Function in Type 1 Diabetes (2011)
Similar Researchers
Based on overlapping research topics